| Stage | SCI | % of rev | HRB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $2.4B | 100.00% | HRB ×2.17 |
| Gross profit | $272M | 24.59% | $1.4B | 56.97% | HRB +32.4pp |
| Operating income | $253M | 22.84% | $1.0B | 43.24% | HRB +20.4pp |
| Pre-tax income | $189M | 17.05% | $1.0B | 42.39% | HRB +25.3pp |
| Net income | $141M | 12.76% | $848M | 35.36% | HRB +22.6pp |
| Stage | SCI | HRB | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $2.4B100.00% | HRB ×2.17 |
| Gross profit | 24.59%$272M | 56.97%$1.4B | HRB +32.4pp |
| Operating income | 22.84%$253M | 43.24%$1.0B | HRB +20.4pp |
| Pre-tax income | 17.05%$189M | 42.39%$1.0B | HRB +25.3pp |
| Net income |
| 12.76%$141M |
| 35.36%$848M |
| HRB +22.6pp |
None
No disclosed counterparties: SCI.